Dr. Velma joined the University of Arizona in January 2021 as a Postdoctoral Research Associate where he actively involved in the AD and Type 2 diabetes (T2D) drug discovery projects. For the last 8 years, he involved in various lead discovery projects in the field of medicinal chemistry and also developed efficient methodologies for the construction of organic frameworks, C-C, C-N, and C-O bond formation reactions which allow new synthetic routes for the preparation of bioactive heterocyclic molecules. Skilled in lead designing, executing multi-step organic synthesis, small heterocyclic molecules (gram scale to mg scale), and purification of high-quality target molecules for various therapeutic applications.
- Ahmed Kamal, V. Ganga Reddy, A. V. Subba Rao, Sd. Riyaz, V. Lakshma Nayak, Shaik Taj, 4Beta-Amidotriazole Linked Podophyllotoxin Derivatives as Potential Anticancer Agents. US10947248B2, WO 2017/154026 A1 (WO: PCT/IN2017/050088) EP 3426661 A1
Postdoctoral Fellow, RMIT-University, Melbourne, Australia, 2020
PhD, CSIR-Indian Institute of Chemical Technology, Hyderabad, India 2019
Msc, Osmania University, Hyderabad, India, 2011
BSc, Osmania University, Hyderabad, India, 2009